We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$286M
AUM Growth
-$3.33M
Cap. Flow
-$27M
Cap. Flow %
-9.44%
Top 10 Hldgs %
48.02%
Holding
78
New
12
Increased
6
Reduced
39
Closed
6

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$1.24M
2
LOW icon
Lowe's Companies
LOW
+$1.05M
3
PG icon
Procter & Gamble
PG
+$704K
4
WMT icon
Walmart Inc
WMT
+$531K
5
GIS icon
General Mills
GIS
+$384K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$11.4M
2
IBB icon
iShares Biotechnology ETF
IBB
+$5.82M
3
GLW icon
Corning
GLW
+$3.16M
4
FDX icon
FedEx
FDX
+$1.41M
5
GLD icon
SPDR Gold Trust
GLD
+$1.35M

Sector Composition

Rank Sector Weight
1 Communication Services 18.38%
2 Consumer Staples 10.5%
3 Materials 10.28%
4 Healthcare 10.04%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
26
Fortuna Silver Mines
FSM
$2.55B
$4.18M 1.46%
638,736
-11,547
-2% -$71.5K
MOS icon
27
The Mosaic Company
MOS
$7.03B
$3.94M 1.38%
107,950
-2,812
-3% -$90.1K
AAPL icon
28
Apple
AAPL
$4.54T
$3.36M 1.17%
16,364
-3,621
-18% -$731K
ADBE icon
29
Adobe
ADBE
$99.5B
$3.34M 1.17%
8,628
-92
-1% -$35.4K
T icon
30
AT&T
T
$159B
$3.33M 1.16%
114,992
-3,960
-3% -$109K
KO icon
31
Coca-Cola
KO
$377B
$3.3M 1.15%
46,627
NKE icon
32
Nike
NKE
$61.9B
$3.16M 1.1%
44,423
-341
-0.8% -$20.5K
ALB icon
33
Albemarle
ALB
$13.9B
$3.13M 1.09%
49,872
-1,804
-3% -$107K
VXUS icon
34
Vanguard Total International Stock ETF
VXUS
$155B
$2.72M 0.95%
39,326
-150
-0.4% -$9.74K
CLX icon
35
Clorox
CLX
$11.6B
$2.68M 0.94%
22,345
-930
-4% -$124K
GLW icon
36
Corning
GLW
$119B
$2.05M 0.72%
38,910
-67,429
-63% -$3.16M
CPB icon
37
Campbell Soup
CPB
$6.55B
$1.96M 0.69%
64,000
-550
-0.9% -$19.4K
SBUX icon
38
Starbucks
SBUX
$120B
$1.81M 0.63%
19,753
+345
+2% +$29.9K
PSLV icon
39
Sprott Physical Silver Trust
PSLV
$12B
$1.2M 0.42%
97,637
PDD icon
40
Pinduoduo
PDD
$126B
$1.12M 0.39%
10,700
LOW icon
41
Lowe's Companies
LOW
$117B
$1.04M 0.36%
+4,689
New +$1.05M
SLV icon
42
iShares Silver Trust
SLV
$28B
$925K 0.32%
28,194
MCD icon
43
McDonald's
MCD
$192B
$920K 0.32%
3,150
-300
-9% -$92.5K
PG icon
44
Procter & Gamble
PG
$336B
$688K 0.24%
+4,316
New +$704K
CGON icon
45
CG Oncology
CGON
$6.28B
$650K 0.23%
25,000
AMZN icon
46
Amazon
AMZN
$2.92T
$611K 0.21%
2,787
-3,220
-54% -$637K
SHV icon
47
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$569K 0.2%
5,150
MSFT icon
48
Microsoft
MSFT
$3.45T
$558K 0.2%
1,122
+196
+21% +$85.1K
WMT icon
49
Walmart Inc
WMT
$885B
$545K 0.19%
+5,573
New +$531K
BNY
50
Bank of New York Mellon
BNY
$106B
$456K 0.16%
5,000

Similar funds

Sicart Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Sicart Associates held 78 positions worth $286M, down 1.2% from $289M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sicart Associates withdrew a net $27M in Q2 2025, closing 6 positions and reducing 39 holdings. Its most notable exit was Gilead Sciences, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Sicart Associates opened a new position in Lowe's Companies worth $1.04M.

  • Sicart Associates's largest Q2 2025 buy was Lowe's Companies: 4,689 shares worth $1.04M.
  • Sicart Associates added most to Guardant Health in Q2 2025, an estimated $1.24M increase.
  • Sicart Associates's biggest Q2 2025 reduction was Corning, cutting an estimated $3.16M.
  • Sicart Associates fully exited Gilead Sciences in Q2 2025, selling an estimated $11.4M.
  • Sicart Associates's ten largest holdings make up 48% of its $286M portfolio in Q2 2025.
  • Sicart Associates opened 12 new positions and closed 6 in Q2 2025.
  • Sicart Associates's portfolio value fell 1.2% quarter-over-quarter to $286M.

Based on Sicart Associates's 13F filing for Q2 2025, filed 18 Jul 2025.